For thousands of patients, the cost of some vital medicines will come down significantly today, after being listed on the pharmaceutical benefits scheme. One of those is for a drug used to treat one the most common auto-immune diseases in the world, with nine out of ten patients being women, and rates especially high among first nations and Asian Australians.